|
US5486359A
(en)
|
1990-11-16 |
1996-01-23 |
Osiris Therapeutics, Inc. |
Human mesenchymal stem cells
|
|
US5736396A
(en)
|
1995-01-24 |
1998-04-07 |
Case Western Reserve University |
Lineage-directed induction of human mesenchymal stem cell differentiation
|
|
US6974571B2
(en)
|
1995-03-28 |
2005-12-13 |
Thomas Jefferson University |
Isolated stromal cells and methods of using the same
|
|
US5827740A
(en)
|
1996-07-30 |
1998-10-27 |
Osiris Therapeutics, Inc. |
Adipogenic differentiation of human mesenchymal stem cells
|
|
US20030103951A1
(en)
|
1997-07-14 |
2003-06-05 |
Osiris Therapeutics, Inc. |
Cardiac muscle regeneration using mesenchymal stem cells
|
|
WO1999003973A1
(en)
|
1997-07-14 |
1999-01-28 |
Osiris Therapeutics, Inc. |
Cardiac muscle regeneration using mesenchymal stem cells
|
|
US6251295B1
(en)
|
1998-01-08 |
2001-06-26 |
Nexell Therapeutics Inc. |
Method for recirculation washing of blood cells
|
|
DE69922933T2
(de)
|
1998-03-13 |
2005-12-29 |
Osiris Therapeutics, Inc. |
Anwendungen für humane nicht autologe, mesenchymale stammzellen
|
|
WO1999047163A2
(en)
|
1998-03-18 |
1999-09-23 |
Osiris Therapeutics, Inc. |
Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
|
|
US6368636B1
(en)
|
1998-03-18 |
2002-04-09 |
Osiris Therapeutics, Inc. |
Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
|
|
US20030118567A1
(en)
|
1999-03-26 |
2003-06-26 |
Stewart Duncan John |
Cell-based therapy for the pulmonary system
|
|
WO1999051247A1
(en)
|
1998-04-03 |
1999-10-14 |
Osiris Therapeutics, Inc. |
Use of human mesenchymal stem cells to induce t-cell apoptosis
|
|
JP2002510655A
(ja)
|
1998-04-03 |
2002-04-09 |
オシリス セラピューティクス,インコーポレイテッド |
免疫抑制剤としての間葉幹細胞によるt細胞応答を阻害する方法とその利用
|
|
US6030836A
(en)
|
1998-06-08 |
2000-02-29 |
Osiris Therapeutics, Inc. |
Vitro maintenance of hematopoietic stem cells
|
|
US8147824B2
(en)
|
1999-08-05 |
2012-04-03 |
Athersys, Inc. |
Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
|
|
AU7611500A
(en)
|
1999-09-24 |
2001-04-24 |
Abt Holding Company |
Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
|
|
US6685936B2
(en)
|
1999-10-12 |
2004-02-03 |
Osiris Therapeutics, Inc. |
Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
|
|
US6936281B2
(en)
|
2001-03-21 |
2005-08-30 |
University Of South Florida |
Human mesenchymal progenitor cell
|
|
US20030104997A1
(en)
|
2001-09-05 |
2003-06-05 |
Black Ira B. |
Multi-lineage directed induction of bone marrow stromal cell differentiation
|
|
US9597395B2
(en)
|
2001-12-07 |
2017-03-21 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
|
US8105580B2
(en)
|
2001-12-07 |
2012-01-31 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to promote wound healing
|
|
US7628988B2
(en)
|
2002-06-27 |
2009-12-08 |
The General Hospital Corporation |
Methods and compositions for treating type 1 diabetes
|
|
EP1551955A4
(en)
|
2002-07-16 |
2006-11-29 |
Yissum Res Dev Co |
METHOD FOR IMPLANTING MESENCHYMAL STEM CELLS FOR TISSUE PAIRING AND FORMATION
|
|
WO2004009767A2
(en)
|
2002-07-23 |
2004-01-29 |
Boston Scientific Limited |
Cell therapy for regeneration
|
|
US20060210544A1
(en)
|
2003-06-27 |
2006-09-21 |
Renomedix Institute, Inc. |
Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
|
|
CA2564679C
(en)
|
2004-03-22 |
2015-06-23 |
Osiris Therapeutics, Inc. |
Mesenchymal stem cells and uses therefor
|
|
ES2385450T3
(es)
|
2004-03-22 |
2012-07-25 |
Osiris Therapeutics, Inc. |
Células madre mesenquimatosas y sus utilizaciones
|
|
JP5162756B2
(ja)
|
2005-04-14 |
2013-03-13 |
財団法人ヒューマンサイエンス振興財団 |
医薬組成物及びその製造方法
|
|
EP1795588A1
(en)
|
2005-12-07 |
2007-06-13 |
Cellerix, S.L. |
Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
|
|
US20070253931A1
(en)
|
2006-01-12 |
2007-11-01 |
Osiris Therapeutics, Inc. |
Use of mesenchymal stem cells for treating genetic diseases and disorders
|
|
CN101370930A
(zh)
|
2006-01-13 |
2009-02-18 |
奥西里斯治疗公司 |
表达TNF-α受体的间充质干细胞
|
|
EP2057195A4
(en)
|
2006-08-29 |
2010-05-12 |
Forhumantech Co Ltd |
PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME
|
|
US20120269774A1
(en)
|
2006-09-21 |
2012-10-25 |
Medistem Laboratories, Inc |
Allogeneic stem cell transplants in non-conditioned recipients
|
|
EP2578677A1
(en)
|
2007-08-09 |
2013-04-10 |
Genzyme Corporation |
Method of treating autoimmune disease with mesenchymal stem cells
|
|
KR101039235B1
(ko)
|
2007-08-29 |
2011-06-07 |
메디포스트(주) |
제대혈 유래 간엽줄기세포를 포함하는 인터루킨-8 또는지알오-알파 발현 세포가 관련된 질병의 진단, 예방 또는치료용 조성물
|
|
KR101995016B1
(ko)
|
2007-12-04 |
2019-06-28 |
프로테오바이오엑티브스 피티와이 엘티디 |
전구 세포의 보호 및 그의 분화 조절
|
|
WO2009154840A2
(en)
|
2008-03-27 |
2009-12-23 |
Neostem, Inc. |
Compositions and methods using stem cells in cutaneous wound healing
|
|
MX2011001730A
(es)
|
2008-08-14 |
2011-03-24 |
Osiris Therapeutics Inc |
Composiciones purificadas de celulas madre mesenquimales y metodos para purificar composiciones de celulas madre mesenquimales.
|
|
WO2011047345A2
(en)
|
2009-10-15 |
2011-04-21 |
Tai June Yoo |
Methods of treating diseases of conditions using mesenchymal stem cells
|
|
KR101871472B1
(ko)
|
2010-07-02 |
2018-06-27 |
메소블라스트, 아이엔씨. |
이식편대숙주 질환의 치료 방법
|
|
CA2809272A1
(en)
|
2010-08-31 |
2012-03-08 |
Cook General Biotechnology Llc |
Systemic, allogenic stem cell therapies for treatment of diseases in animals
|
|
WO2012048093A2
(en)
|
2010-10-08 |
2012-04-12 |
Osiris Therapeutics, Inc. |
Enhanced msc preparations
|
|
EP2714057B1
(en)
|
2011-06-03 |
2019-11-06 |
Mesoblast, Inc. |
Methods of treating or preventing neurological diseases
|
|
US20140134140A1
(en)
|
2012-11-09 |
2014-05-15 |
Case Western Reserve University |
Mesenchymal stem cell compositions for the treatment of microbial infections
|
|
JP6173157B2
(ja)
|
2013-10-02 |
2017-08-02 |
日本製薬株式会社 |
Il−17産生抑制組成物
|
|
WO2015061839A1
(en)
|
2013-11-04 |
2015-05-07 |
Sturm Marian June |
Cell culture method
|
|
CN114317461A
(zh)
|
2013-11-22 |
2022-04-12 |
德那翠丝有限公司 |
表达免疫细胞刺激受体激动剂的腺病毒
|
|
KR102577698B1
(ko)
|
2014-04-07 |
2023-09-12 |
메조블라스트 인터내셔널 에스에이알엘 |
개선된 줄기 세포 조성물
|
|
WO2015189063A1
(en)
|
2014-06-10 |
2015-12-17 |
Mesoblast International Sàrl |
Treatment of immune disorders
|
|
WO2016086020A1
(en)
|
2014-11-24 |
2016-06-02 |
Cytostormrx Llc |
Encapsulated stem cells for the treatment of inflammatory disease
|
|
CN107206027A
(zh)
|
2014-12-23 |
2017-09-26 |
迈索布拉斯特国际有限公司 |
进行性心力衰竭的预防
|
|
US20180037867A1
(en)
|
2015-03-04 |
2018-02-08 |
Mesoblast International Sàrl |
Cell culture method for mesenchymal stem cells
|
|
AU2016258980B2
(en)
|
2015-05-05 |
2022-02-17 |
Mesoblast International Sàrl |
Potency assay
|
|
JP7082372B2
(ja)
|
2017-02-15 |
2022-06-08 |
ロート製薬株式会社 |
肺線維症治療剤、ptprr発現促進剤及び肺線維症治療用キット
|
|
EP3619294A1
(en)
|
2017-05-04 |
2020-03-11 |
Mesoblast International Sàrl |
Mesenchymal lineage precursor or stem cells with enhanced immunosuppression
|
|
CL2017002357A1
(es)
|
2017-09-16 |
2018-04-20 |
Cells For Cells S A |
Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos
|
|
WO2019102268A1
(en)
|
2017-11-22 |
2019-05-31 |
Mesoblast International Sarl |
Cellular compositions and methods of treatment i
|
|
EP4772245A3
(en)
|
2019-01-02 |
2026-08-19 |
Mesoblast International Sàrl |
Method for treating lower back pain
|
|
US12702683B2
(en)
|
2019-01-03 |
2026-08-11 |
Mesoblast International Sárl |
Method for improving visual acuity
|
|
US20220160776A1
(en)
|
2019-01-28 |
2022-05-26 |
Mesoblast International Sárl |
Method for treating or preventing gastrointestinal bleeding
|
|
CN113853206A
(zh)
|
2019-05-23 |
2021-12-28 |
迈索布拉斯特国际有限公司 |
脑梗塞的功能恢复
|
|
EP3994245A1
(en)
|
2019-07-05 |
2022-05-11 |
Case Western Reserve University |
Priming media and methods for stem cell culture and therapy
|
|
KR20220038485A
(ko)
|
2019-08-05 |
2022-03-28 |
메조블라스트 인터내셔널 에스에이알엘 |
바이러스 벡터를 포함하는 세포 조성물 및 치료 방법
|
|
KR20220143092A
(ko)
|
2020-02-19 |
2022-10-24 |
메조블라스트 인터내셔널 에스에이알엘 |
만성 이식편 대 숙주 질환의 치료 방법
|
|
CN111297899A
(zh)
*
|
2020-02-21 |
2020-06-19 |
云南雅盛医疗科技有限公司 |
一种脐带间充质干细胞在制备治疗新型冠状肺炎药物中的应用
|
|
WO2021176001A1
(en)
|
2020-03-05 |
2021-09-10 |
Mesoblast International Sàrl |
Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
|
|
CN115297875A
(zh)
|
2020-03-11 |
2022-11-04 |
迈索布拉斯特国际有限公司 |
治疗炎症性肠病的方法ii
|
|
BR112022017560A2
(pt)
|
2020-03-11 |
2022-12-27 |
Mesoblast Int Sarl |
Método para tratar doença inflamatória intestinal i
|
|
JP2023520233A
(ja)
|
2020-04-03 |
2023-05-16 |
メゾブラスト・インターナショナル・エスアーエールエル |
間葉系統前駆細胞又は幹細胞を使用する過炎症の治療方法
|
|
JP2023524660A
(ja)
|
2020-04-28 |
2023-06-13 |
ファクター バイオサイエンス インコーポレイテッド |
間葉系幹細胞療法
|
|
CA3181611A1
(en)
|
2020-06-11 |
2021-12-16 |
Paul Simmons |
3d culture of mesenchymal lineage precursor or stem cells
|
|
US20230398154A1
(en)
|
2020-08-10 |
2023-12-14 |
Mesoblast International Sárl |
A composition comprising mesenchymal precursor or stem cells and their use
|
|
CN115996735A
(zh)
|
2020-08-10 |
2023-04-21 |
迈索布拉斯特国际有限公司 |
细胞组合物和治疗方法
|
|
WO2022132986A2
(en)
|
2020-12-15 |
2022-06-23 |
Mesoblast International Sarl |
Method of treating progressive heart failure in subjects with class ii heart failure
|
|
CN112522191B
(zh)
|
2020-12-18 |
2023-05-12 |
云南中科灵长类生物医学重点实验室 |
一种间充质干细胞的培养方法
|
|
AU2022210364A1
(en)
|
2021-01-22 |
2023-08-31 |
Mesoblast International Sàrl |
Opioid sparing compositions and methods of using the same
|
|
BR112023021840A2
(pt)
|
2021-04-23 |
2024-02-06 |
Mesoblast Int Sarl |
Método para tratar síndrome da dificuldade respiratória aguda (ards) com o uso de percursor de linhagem mesenquimal ou células-tronco
|
|
AU2022394471A1
(en)
|
2021-11-17 |
2024-06-20 |
Mesoblast International Sarl |
Method of treating progressive heart failure in subjects at high risk of poor outcomes
|
|
US20250032552A1
(en)
|
2021-12-23 |
2025-01-30 |
Mesoblast International Sárl |
Method of treating severe graft versus host disease
|
|
CA3257272A1
(en)
|
2022-05-26 |
2023-11-30 |
Mesoblast International Sàrl |
HIGH FLOW FILTER AND METHOD OF USE
|
|
EP4536253A1
(en)
|
2022-06-08 |
2025-04-16 |
Mesoblast International Sàrl |
Mesenchymal progenitor cells for enhancing partial reprogramming of target cells
|